BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 15549413)

  • 21. Cardiovascular calcification in nondialyzed patients with chronic kidney disease.
    Qunibi WY
    Semin Dial; 2007; 20(2):134-8. PubMed ID: 17374087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitral valve repair for medically refractory functional mitral regurgitation in patients with end-stage renal disease and advanced heart failure.
    Kainuma S; Taniguchi K; Daimon T; Sakaguchi T; Funatsu T; Miyagawa S; Kondoh H; Takeda K; Shudo Y; Masai T; Ohishi M; Sawa Y
    Circulation; 2012 Sep; 126(11 Suppl 1):S205-13. PubMed ID: 22965985
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hyperphosphatemia and cardiovascular risk in patients on dialysis].
    Basić-Jukić N; Kes P
    Acta Med Croatica; 2004; 58(3):207-13. PubMed ID: 15503684
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eccentric Left Ventricular Hypertrophy and Sudden Death in Patients with End-Stage Kidney Disease.
    de Roij van Zuijdewijn CL; Hansildaar R; Bots ML; Blankestijn PJ; van den Dorpel MA; Grooteman MP; Kamp O; ter Wee PM; Nubé MJ
    Am J Nephrol; 2015; 42(2):126-33. PubMed ID: 26382055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cardiac anomalies in chronic renal failure].
    Guérin A; Marchais S; Pannier B; London G
    Presse Med; 2000 Feb; 29(5):274-80. PubMed ID: 10701411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Cardiovascular Events on End-Stage Renal Disease and Mortality in Patients With Chronic Kidney Disease Before Dialysis.
    Kuwahara M; Takehara E; Sasaki Y; Azetsu H; Kusaka K; Shikuma S; Akita W
    Ther Apher Dial; 2016 Feb; 20(1):12-9. PubMed ID: 26679409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of calcium on cardiovascular events in patients with kidney disease and in a healthy population.
    West SL; Swan VJ; Jamal SA
    Clin J Am Soc Nephrol; 2010 Jan; 5 Suppl 1():S41-7. PubMed ID: 20089502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cardioprotection: an essential component for predialysis chronic renal failure treatment].
    Jungers P; Qualim Z; Nguyen-Khoa T; Massy Z; London G
    Nephrologie; 2003; 24(2):79-88. PubMed ID: 12723513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular calcification in end-stage renal disease.
    Goodman WG
    J Nephrol; 2002; 15 Suppl 6():S82-5. PubMed ID: 12515378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel cardiovascular risk factors in end-stage renal disease.
    Zoccali C; Mallamaci F; Tripepi G
    J Am Soc Nephrol; 2004 Jan; 15 Suppl 1():S77-80. PubMed ID: 14684678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular calcification and ESRD: a hard target.
    Bhan I; Thadhani R
    Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S102-5. PubMed ID: 19995990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Calcification and degeneration following mitral valve reconstruction in patients requiring chronic dialysis.
    Lewandowski TJ; Armstrong WF; Bolling SF; Bach DS
    J Heart Valve Dis; 2000 May; 9(3):364-9. PubMed ID: 10888092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular disease in end stage renal disease.
    Sharma R; Pellerin D; Brecker SJ
    Minerva Urol Nefrol; 2006 Jun; 58(2):117-31. PubMed ID: 16767066
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Cardiac valves calcifications in dialysis patients].
    Klarić D; Klarić V; Kristić I
    Acta Med Croatica; 2011 Oct; 65 Suppl 3():11-3. PubMed ID: 23120808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The role of major vessels remodeling in development of left ventricular hypertrophy in patients with a predialysis stage of chronic renal failure].
    Kutyrina IM; Rudenko TE; Shvetsov MIu; Kushnir VV
    Ter Arkh; 2008; 80(6):37-41. PubMed ID: 18655474
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular disease in children with chronic kidney disease.
    Mitsnefes MM
    Adv Chronic Kidney Dis; 2005 Oct; 12(4):397-405. PubMed ID: 16198279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Vascular stiffness in chronic renal failure patients treated by hemodialysis].
    Posadzy-Małaczyńska A; Wanic-Kossowska M; Tykarski A; Czekalski S; Głuszek J; Kosch M
    Pol Arch Med Wewn; 2005 Nov; 114(5):1072-8. PubMed ID: 16789505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac consequences of hypertension in hemodialysis patients.
    Zoccali C; Benedetto FA; Tripepi G; Mallamaci F
    Semin Dial; 2004; 17(4):299-303. PubMed ID: 15250922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular calcifications in uremic patients: clinical impact on cardiovascular function.
    London GM
    J Am Soc Nephrol; 2003 Sep; 14(9 Suppl 4):S305-9. PubMed ID: 12939386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.